Attached files
Exhibit 32.1
AMPIO PHARMACEUTICALS, INC. AND SUBSIDIARIES
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended March 31, 2011 (the Report) by Ampio Pharmaceuticals, Inc. (the Company), each of the undersigned hereby certifies that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: May 13, 2011 | /S/ DONALD B. WINGERTER, JR. | |||||
Donald B. Wingerter, Jr. Chief Executive Officer | ||||||
Dated: May 13, 2011 | /S/ Mark D. McGregor | |||||
Mark D. McGregor Chief Financial Officer |